Synonyms: (4S)-2-Oxoclopidogrel | compound IV-1 [EP3290423B1] [3] | compound of formula I [US2022028976]
Compound class:
Synthetic organic
Comment: Becondogrel is the INN for a platelet aggregation inhibitor (WHO proposed INN list 132, Feb 2025). It is a derivative of the irreversible P2Y12 receptor anti-platelet prodrug clopidogrel that has been modified to overcome individual differences in hepatic CYP450 enzyme activity that limit conversion of clopidogrel into its active metabolite [1-2] and conversion to an inactive carboxylic derivative by carboxylesterase 1 (CES1) [4]. Becondogrel is a prodrug that is converted to its active metabolite in vivo.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
methyl (2S)-2-[(7aS)-2-oxo-4,6,7,7a-tetrahydrothieno[3,2-c]pyridin-5-yl]-2-(2-chlorophenyl)acetate |
International Nonproprietary Names ![]() |
|
INN number | INN |
13296 | becondogrel |
Synonyms ![]() |
|
(4S)-2-Oxoclopidogrel | compound IV-1 [EP3290423B1] [3] | compound of formula I [US2022028976] |
Database Links ![]() |
|
CAS Registry No. | 1416696-44-0 (source: WHO INN record) |
GtoPdb PubChem SID | 507750435 |
PubChem CID | 29986184 |
Search Google for chemical match using the InChIKey | JBSAZVIMJUOBNB-ZFWWWQNUSA-N |
Search Google for chemicals with the same backbone | JBSAZVIMJUOBNB |
Search PubMed clinical trials | becondogrel |
Search PubMed titles | becondogrel |
Search PubMed titles/abstracts | becondogrel |
UniChem Compound Search for chemical match using the InChIKey | JBSAZVIMJUOBNB-ZFWWWQNUSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | JBSAZVIMJUOBNB-ZFWWWQNUSA-N |